1
982 columns of figures do not allow for what is perhaps the decisive (and least understood) factor in the prognosis of an individual case-the rate of growth of the cancer. This collective survey reveals no striking advance in the results of treatment over the past 30 years. But it is by standard methods of staging and by careful follow-up, as in this study, that the first signs of a break-through will be recognised. ST. JOHN’S HOSPITAL St. John’s Hospital for Diseases of the Skin, with which is associated the University of London’s post- graduate Institute of Dermatology, is celebrating the centenary of its foundation with a reception at the Royal College of Physicians and the publication of the hospital’s history. 1 John Laws Milton, its founder, was at first its sole medical officer, but he was joined in 1864 by Erasmus Wilson, Tilbury Fox, and J. Mill Frodsham. Unfortu- nately a dispute occurred, and the three soon felt com- pelled to resign, but the activities of the hospital con- tinued to grow slowly. At first situated in Church-street, now Romilly-street, it soon moved to the west side of Leicester-square, to the building now occupied by the Automobile Association. In its first 60 years the hospital faced many vicissitudes, including at one time near- ostracism as far as professional relationships were con- cerned. But in 1923 Dr. James H. Stowers, Sir Malcolm Morris, and other eminent dermatologists between them managed to break the barrier between St. John’s Hospital and the teaching hospitals, and a number of physicians attached to their dermatological departments were appointed to the staff at St. John’s Hospital. The London School of Dermatology was formed in 1923, and in 1936 the hospital moved to its present site in Lisle-street. The Institute of Dermatology took over the London School of Dermatology in 1946, and in 1948 St. John’s Hospital was designated a teaching hospital. In 1959 the Institute of Dermatology was recognised as a federated institute of the British Postgraduate Medical Federation, and in 1961 a chair in dermatology was established. The hospital and institute are at present seriously hampered by lack of space and the separation of the inpatient department at Homerton from the outpatient building in Leicester-square; but some 10 years or more will have to pass before inpatients, outpatients, research, and teaching can be brought under one roof within the proposed new postgraduate centre of hospitals and institutes at Chelsea. A NEW ANTISEPTIC THE isolation from hospital patients of bacteria resistant to most if not all of the available antibiotics is becoming increasingly common. These bacteria are often found as secondary invaders in superficial lesions such as bedsores, trophic ulcers, and burns, especially in chronically ill or debilitated patients and in patients with chronic ulcerating conditions of the skin. In hospital, lesions of this type can form reservoirs of antibiotic-resistant organisms from which more serious systemic infections may arise not only in the patient harbouring the organism but also by cross- infection to others. Treatment with systemic antibiotics 1. St. John’s Hospital for Diseases of the Skin 1863-1963. By BRIAN RUSSELL. Edinburgh: E. & S. Livingstone. 1963. Pp. 70. 27s. 6d. may help to localise the lesion but often merely results in infection by a more resistant organism, while topical application of antibiotics favours the emergence of resis- tant variants during treatment besides carrying an appre- ciable risk of sensitising the patient. Before the discovery of antibiotics, the usual form of treatment of this type of lesion was local application of germicidal substances, and a return to this practice seems justified in many cases. Many of these substances, how- ever, are of limited value. Those whose activity depends on the presence of halogen are rapidly inactivated in the presence of organic material such as purulent debris, serum, or blood; phenolic disinfectants are too toxic; and quaternary ammonium compounds are much less active against gram-negative than against gram-positive organ- isms, Pseudomonaspyocyanea being particularly resistant. 1-3 Consequently the search for new germicidal substances with a wider spectrum of antibacterial and antifungal activity continues. , Promising results have been reported with Poly- noxylin’, a condensation product of formaldehyde and urea,4 5 which is active against a wide variety of gram- positive and gram-negative organisms as well as certain pathogenic fungi. How this substance acts has not been established, but the absence of irritant properties suggests that activity is probably not due to the liberation of free formaldehyde.5 The reported studies do not make clear the rate and degree of killing produced by polynoxylin or the effect of organic material on its activity. The many inherent difficulties in the testing of chemical disinfect- ants 6-8 may lead to over-optimistic claims of activity:8 The importance of estimating the degree of killing by a chemical disinfectant, and the limitations of the theoret- ical assumptions involved, are well shown by cases of poliomyelitis occurring after vaccination with certain commercial lots of vaccine,9 which had been prepared according to specifications regarded as safe. Neverthe- less, the promising results so far obtained with polynoxy- lin seem to justify further investigation of its germicidal properties and clinical worth. POISONING IN THE HOME AT a plenary session of the Third International Meeting in Forensic Immunology, Medicine, Pathology, and Toxicology, which ended in London last week, the discus- sion on poisoning in the home centred on incidence and prevention rather than on treatment. Among figures produced to illustrate this worldwide problem, those from the United States showed that more children were killed by accidental poisoning than by a number of infant diseases put together. The public were still not sufficiently aware of the dangers, and more propaganda was needed, especially about the safe keeping of noxious agents and the dangers of a number of domestic substances, including insecticides. Already some places had preventive pro- grammes for the laymen, and there were information centres where people could get advice by phone; but more effort was needed along these lines. The idea of poison information centres was discussed, 1. Lowbury, E. J. L. Brit. J. industr. Med. 1951, 8, 22. 2. Anderson, K., Keynes, R. Brit. med. J. 1958, ii, 274. 3. Plotkin, S. A., Austrian, R. Amer. J. med. Sci. 1958, 235, 621. 4. Haler, D., Aebi, A. Nature, Lond. 1961, 190, 734. 5. Haler, D. ibid. 1963, 198, 400. 6. Wyss, D. Ann. Rev. Microbiol. 1948, 2, 413. 7. Phillips, C. R., Warshowsky, B. ibid. 1958, 12, 525. 8. Williams, R. E. O., Blowers, R., Garrod, L. P., Shooter, R. A. Hospital Infection: Causes and Prevention. London, 1960. 9. Meier, P. Science, 1957, 125, 1067.

ST. JOHN'S HOSPITAL

Embed Size (px)

Citation preview

Page 1: ST. JOHN'S HOSPITAL

982

columns of figures do not allow for what is perhaps thedecisive (and least understood) factor in the prognosisof an individual case-the rate of growth of the cancer.

This collective survey reveals no striking advance inthe results of treatment over the past 30 years. But it is bystandard methods of staging and by careful follow-up,as in this study, that the first signs of a break-through willbe recognised.

ST. JOHN’S HOSPITAL

St. John’s Hospital for Diseases of the Skin, withwhich is associated the University of London’s post-graduate Institute of Dermatology, is celebrating the

centenary of its foundation with a reception at the RoyalCollege of Physicians and the publication of the hospital’shistory. 1

John Laws Milton, its founder, was at first its solemedical officer, but he was joined in 1864 by ErasmusWilson, Tilbury Fox, and J. Mill Frodsham. Unfortu-

nately a dispute occurred, and the three soon felt com-pelled to resign, but the activities of the hospital con-tinued to grow slowly. At first situated in Church-street,now Romilly-street, it soon moved to the west side of

Leicester-square, to the building now occupied by theAutomobile Association. In its first 60 years the hospitalfaced many vicissitudes, including at one time near-

ostracism as far as professional relationships were con-cerned. But in 1923 Dr. James H. Stowers, Sir MalcolmMorris, and other eminent dermatologists between themmanaged to break the barrier between St. John’s Hospitaland the teaching hospitals, and a number of physiciansattached to their dermatological departments were

appointed to the staff at St. John’s Hospital.The London School of Dermatology was formed in

1923, and in 1936 the hospital moved to its present sitein Lisle-street. The Institute of Dermatology took overthe London School of Dermatology in 1946, and in 1948St. John’s Hospital was designated a teaching hospital.In 1959 the Institute of Dermatology was recognised asa federated institute of the British Postgraduate MedicalFederation, and in 1961 a chair in dermatology wasestablished.The hospital and institute are at present seriously

hampered by lack of space and the separation of theinpatient department at Homerton from the outpatientbuilding in Leicester-square; but some 10 years or morewill have to pass before inpatients, outpatients, research,and teaching can be brought under one roof within theproposed new postgraduate centre of hospitals andinstitutes at Chelsea.

A NEW ANTISEPTIC

THE isolation from hospital patients of bacteria resistantto most if not all of the available antibiotics is becomingincreasingly common. These bacteria are often found assecondary invaders in superficial lesions such as bedsores,trophic ulcers, and burns, especially in chronically ill ordebilitated patients and in patients with chronic ulceratingconditions of the skin. In hospital, lesions of this typecan form reservoirs of antibiotic-resistant organisms fromwhich more serious systemic infections may arise not onlyin the patient harbouring the organism but also by cross-infection to others. Treatment with systemic antibiotics1. St. John’s Hospital for Diseases of the Skin 1863-1963. By BRIAN RUSSELL.

Edinburgh: E. & S. Livingstone. 1963. Pp. 70. 27s. 6d.

may help to localise the lesion but often merely results ininfection by a more resistant organism, while topicalapplication of antibiotics favours the emergence of resis-tant variants during treatment besides carrying an appre-ciable risk of sensitising the patient.

Before the discovery of antibiotics, the usual form oftreatment of this type of lesion was local application ofgermicidal substances, and a return to this practice seemsjustified in many cases. Many of these substances, how-ever, are of limited value. Those whose activity dependson the presence of halogen are rapidly inactivated in thepresence of organic material such as purulent debris,serum, or blood; phenolic disinfectants are too toxic; andquaternary ammonium compounds are much less activeagainst gram-negative than against gram-positive organ-isms, Pseudomonaspyocyanea being particularly resistant. 1-3Consequently the search for new germicidal substanceswith a wider spectrum of antibacterial and antifungalactivity continues.,

Promising results have been reported with Poly-noxylin’, a condensation product of formaldehyde andurea,4 5 which is active against a wide variety of gram-positive and gram-negative organisms as well as certainpathogenic fungi. How this substance acts has not beenestablished, but the absence of irritant properties suggeststhat activity is probably not due to the liberation of freeformaldehyde.5 The reported studies do not make clearthe rate and degree of killing produced by polynoxylin orthe effect of organic material on its activity. The manyinherent difficulties in the testing of chemical disinfect-ants 6-8 may lead to over-optimistic claims of activity:8The importance of estimating the degree of killing by achemical disinfectant, and the limitations of the theoret-ical assumptions involved, are well shown by cases ofpoliomyelitis occurring after vaccination with certaincommercial lots of vaccine,9 which had been preparedaccording to specifications regarded as safe. Neverthe-

less, the promising results so far obtained with polynoxy-lin seem to justify further investigation of its germicidalproperties and clinical worth.

POISONING IN THE HOME

AT a plenary session of the Third International Meetingin Forensic Immunology, Medicine, Pathology, and

Toxicology, which ended in London last week, the discus-sion on poisoning in the home centred on incidence andprevention rather than on treatment. Among figuresproduced to illustrate this worldwide problem, those fromthe United States showed that more children were killed

by accidental poisoning than by a number of infantdiseases put together. The public were still not sufficientlyaware of the dangers, and more propaganda was needed,especially about the safe keeping of noxious agents andthe dangers of a number of domestic substances, includinginsecticides. Already some places had preventive pro-grammes for the laymen, and there were informationcentres where people could get advice by phone; but moreeffort was needed along these lines.The idea of poison information centres was discussed,

1. Lowbury, E. J. L. Brit. J. industr. Med. 1951, 8, 22.2. Anderson, K., Keynes, R. Brit. med. J. 1958, ii, 274.3. Plotkin, S. A., Austrian, R. Amer. J. med. Sci. 1958, 235, 621.4. Haler, D., Aebi, A. Nature, Lond. 1961, 190, 734.5. Haler, D. ibid. 1963, 198, 400.6. Wyss, D. Ann. Rev. Microbiol. 1948, 2, 413.7. Phillips, C. R., Warshowsky, B. ibid. 1958, 12, 525.8. Williams, R. E. O., Blowers, R., Garrod, L. P., Shooter, R. A. Hospital

Infection: Causes and Prevention. London, 1960.9. Meier, P. Science, 1957, 125, 1067.